Implications of continued response after autologous stem cell transplantation for multiple myeloma

Patients undergoing autologous stem cell transplantation (ASCT) for multiple myeloma (MM) undergo disease assessment approximately 100 days later. Some patients continue to have a decline in their serum or urine monoclonal protein after day 100 in the absence of additional therapy. We evaluated 430...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gonsalves, Wilson I., Gertz, Morie A., Dispenzieri, Angela, Lacy, Martha Q., Lin, Yi, Singh, Preet P., Gupta, Vinay, Hayman, Suzanne R., Buadi, Francis K., Dingli, David, Kapoor, Prashant, McCurdy, Arleigh R., Kumar, Shaji K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2013
Konular:
Lymphoid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3765057/
https://ncbi.nlm.nih.gov/pubmed/23863899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-03-492678
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller